Global data shows that nausea, vomiting, diarrhoea, and constipation are the most common GLP-1 side effects, affecting a large proportion of users [1][4]
Defects in the BCAA metabolism-related gene, protein phosphatase Mg 2+ /Mn 2+ -dependent 1 K (PPM1K), can disrupt energy metabolism homeostasis within the follicular microenvironment, potentially leading to PCOS-like phenotypes 15
Neves LF, Duan J, Voelker A, Khanal A, McNally L, Steinbach-Rankins J, et al
(Saudi Arabia, Kuwait, Qatar, Oman, Bahrain) Yes
While Basaglar can be prescribed for both type 1 and type 2 diabetes in adults and also in children aged 6+, Ozempic, however, is only approved for type 2 diabetes & isnt an option for people with type 1 diabetes TL;DR Basaglar (insulin glargine) and Ozempic (semaglutide) treat type 2 diabetes through completely different mechanisms Basaglar is a long acting basal insulin injected daily that directly replaces insulin your body lacks while Ozempic is a GLP 1 receptor agonist injected weekly that enhances your bodys natural insulin production Key differences: Ozempic promotes weight loss (10-15%) while Basaglar often causes weight gain Ozempic reduces A1C by 1.4-1.8% vs Basaglars 0.8-1.5%
Turmeric is a delicious spice that is frequently incorporated into dishes for flavoring, but it also has a variety of health benefits
